Lotus Ventures Inc (CSE:J) or (the “Company”) met with David Hyde & Associates last week to discuss the final steps prior to submitting its evidence package to Health Canada. The overall impact of the meeting was positive, as security is a large portion of the package. 100 on-site security cameras, perimeter fencing and the production vault have all been installed and are operational.

Lotus set an anticipated date with Mr. Hyde and his team, to return to the facility in December to film and finalize the evidence package. The package can then be edited and submitted to Health Canada and the Lotus cultivation license should be issued shortly thereafter.


O’Cannabiz and Lift & Co. Expo Vancouver

A portion of the Lotus team will be attending both O’Cannabiz Expo (December 10-11) and the Lift & Co. Cannabis Expo (January 10-13) in Vancouver, BC. The team invites shareholders to attend, as this will be a great opportunity to discuss the company’s strategy and plans for 2019.

ON BEHALF OF THE BOARD
Lotus Ventures Inc.
“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.
Lotus is a late stage licensed producer applicant under the Cannabis Act, in active review with Health Canada. The unique business model combines an upstream royalty financing model with Auxly and a downstream licensing model with farmer/grower partners using Lotus technology and intellectual property. The first facility in Spallumcheen, B.C. is a purpose built, “state of the art” indoor facility with proprietary processes.

For further information: Dale McClanaghan: dalemcclanaghan@gmail.com(604) 644-9844 or Daniel McRobert, Communications danielmcrobertt@gmail.com (604) 842-4625

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation. 

Source: www.lotusventures.ca

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less